Annovis Bio Stock Jumps As New Data Shows Buntanetap Halts Cognitive Decline In Parkinson's Patients
Small Cap Annovis Bio Inc. (NYSE: ANVS) stock is trading higher on Monday, with a session volume of 12.29 million compared to the average volume of 615.12 thousand as per data from Benzinga Pro. A ...
Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from ...
Shares of Gossamer Bio (NASDAQ:GOSS) traded higher on Wednesday after UBS upgraded the California-based biotech to Buy from Neutral, citing an “underappreciated” late-stage data catalyst related to ...
Competition is coming for BioMarin’s potential blockbuster Voxzogo, but the California biotech may be able to answer with a longer-acting version of the C-type natriuretic peptide (CNP), which treats ...
Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...
INmune Bio Inc. (NASDAQ:INMB) stock is trading higher on Friday, with a session volume of 10.26 million compared to the average volume of 519.5K, per data from Benzinga Pro. On Thursday, INmune Bio ...
Living 150 years could not just be possible – it could soon be inevitable, according to human biologist and biohacker Gary Brecka. "If you're alive in five years, I believe it will be your choice ...
With President Donald Trump’s return to the White House and the US government’s digital surveillance machine more powerful than ever, digital privacy should be top of mind. But the digital security ...
A priceless treasure trove of biodata gathered from generations of Americans by Harvard University researchers may soon be lost due to additional funding cuts by the Trump administration, a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results